Brief: ExpreS2ion Biotech Holding: Proof-Of-Concept For Cross-Strain Protective Flu CVLP Vaccine Strengthens Confidence In Coronavirus Vaccine

ExpreS2ion Biotech Holding AB

17/07/2020 07:56

July 17 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * STRONG PROOF-OF-CONCEPT FOR CROSS-STRAIN PROTECTIVE FLU
CVLP
VACCINE FURTHER STRENGTHENS CONFIDENCE IN CORONAVIRUS VACCINE
    * ADAPTVAC ANNOUNCED PUBLICATION OF PAPER IN JOURNAL
VACCINES,
WHERE ITS FLU CVLP VACCINE INDUCED MORE POTENT, LONG-LASTING
IMMUNE RESPONSE
    * ADAPTVAC ANNOUNCED PUBLICATION OF PAPER IN JOURNAL
VACCINES,
WHERE ITS FLU CVLP VACCINE WAS ABLE TO PROTECT MICE AGAINST BOTH
HOMOLOGOUS AND HETEROLOGOUS H1N1 INFLUENZA CHALLENGE, EVEN AFTER
A SINGLE DOSE

Source text for Eikon:  ID:nWkr3MsLQm 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))